Women & Infants Hospital Of Rhode Island

Women & Infants Hospital Of Rhode Island, a tax-exempt nonprofit hospital based in Providence, Rhode Island, operates as a federal grant recipient conducting clinical and translational research in maternal and perinatal health, with 62% of its recent federal awards as prime recipient and 38% as sub-recipient across NIH-funded research programs. The hospital has no federal contracts; its federal activity is entirely grant-funded, centered on NIH extramural research through the National Institute of Child Health and Human Development and affiliated institutes.

The hospital's customer concentration is heavily weighted to the National Institutes of Health, which accounts for 67% of recent awards. The National Institute of Child Health and Human Development (NICHD) alone funds 45 awards with $44.3 million in combined potential value, anchoring the portfolio. The National Heart Lung and Blood Institute, the National Institute of Mental Health, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Institute of Nursing Research comprise the remainder of the top-tier funding agencies. The hospital served 27 distinct federal agencies in the source data window, though NIH entities dominate substantially.

Women & Infants Hospital's research portfolio is concentrated in maternal and perinatal outcomes research, neonatal health, and women's health across the lifespan. Recent prime grant awards represent $248,999 in NICHD funding from May 2026 through June 2029 for "Nourishing Beginnings: The Role of Prenatal Nutrition in Offsetting Stress-Related Developmental Risks," a longitudinal study examining maternal prenatal stress and nutrition intervention effects on child cognitive and neural development using EEG assessment and telomere biomarkers. The hospital is also recipient of congressionally directed spending grants from the Healthcare Systems Bureau for construction of an in-hospital birth center (award date September 30, 2024, completion June 2027) and for perinatal health equity research through an Office of Minority Health grant (award date September 30, 2023, completion September 2027) supporting the Rhode Island Community-Based Maternal Support Services Bundle. Additional prime awards include NICHD-funded research on prenatal genetic counseling via chatbot intervention (award date September 18, 2024, completion August 2029), caregiving influences on attention and executive function in very preterm children (award date August 16, 2024, completion July 2027), neurobiobehavioral underpinnings of intergenerational obesity (award date August 15, 2024, completion May 2029), technology-based collaborative care for postpartum hypertension management (award date August 15, 2024, completion June 2029), and ovarian reserve preservation research through the National Institute of Child Health and Human Development (award date April 1, 2024, completion January 2029).

Activity has grown substantially — from 6 awards in 2022 to 29 awards in 2024 — with 11 awards reaching ultimate completion in the next twenty-four months and therefore facing recompete exposure. The hospital acts as sub-recipient on grants from Brown University, Northwestern University, Rhode Island Hospital, The Miriam Hospital, and other anchor institutions, contributing clinical recruitment, patient assessment, biomarker collection, and site-specific research oversight. Across SCI-reportable federal service contracts, the hospital shows minimal penetration, with a single SCI record carrying 0.2 FTEs in FY2024 as a named subcontractor; this reflects the hospital's grant-funded research posture rather than service-contract engagement. The combined potential value across all 183 awards (prime and sub, contracts and grants) reached $44.7 million, though obligated dollars of $258.2 million reflect substantial prior-year funding flowing through ongoing grant renewals and subaward distributions.